Navigation Links
Taiwan Researchers Claim Cancer Therapy Alternative

Taiwan researchers said Thursday they have successfully tested 10 new sugar-fat compounds they believe will inhibit cancer growth while prolonging patients' survival time with limited side effects. The new compounds were created by a team led by Dr. Wong Chi-huey, president of Taiwan's highest academic research body, the Academia Sinica, and an expert in the structure and function of sugars.

"This is an innovative strategy in cancer treatment. So far, most anti-cancer drugs are associated with side-effects like nausea and hair loss," said Alice Yu, who led a team to validate the compounds. "But the new (compounds) are expected to cause few side-effects as they are designed to enhance immunity rather than attack cancer cells." The new compounds are an improvement on one called a-Galcer, which was discovered in Japan in 1995.

At least 10 of the new compounds had proved effective in experiments with mice, Academia Sinica said. The study showed that lung cancer-bearing mice treated with the new compound had significantly prolonged survival time compared to those treated with a-Galcer, the research institute said in a statement. The Japanese research did not go beyond a phase I trial because while A-Galcer was found to enhance immunity by helping some proteins, it also damaged other proteins, thus suppressing immune functions.

Overall the anti-cancer results were weak. However, Taiwan's experiments showed that mice treated with the new compounds for six weeks appeared to be in better health. In breast cancer-bearing mice, treatment with the new compounds had inhibited tumor growth in 75 percent of the group, compared to 50 percent inhibition of tumor growths in mice treated with a-Galcer.

Encouraged by the experiments, Dr. Chang Ya-jen, another researcher involved in the study, said the new compounds could be used to manufacture drugs that would "provide an alternative therapeutic approach" to cancer management in the future. "They could signal a new ray of hope to cancer patients because such drugs could not only extend their survival time but also improve their life quality while battling with cancer," she said.

The study's results have been published in an online early edition report of the US' PNAS (Proceedings of National Academy of Sciences). Yu said it may take up to 10 years for completion of clinical experiments that would precede mass production of a new cancer therapy drug. Academia Sinica has applied for patent rights here and abroad for the special compounds.


'"/>




Related medicine news :

1. SARS-Free Taiwan to Mark End Phase of Global Fight
2. Taiwanese Had A Hearty Laugh On World Laughter Day
3. Surge of HIV Cases in Taiwan Prompts Doubling in Expenditure for HIV Prevention
4. Taiwan Skincare Empire Built on Natural Beauty
5. Researchers urge caution in using ear tube surgery
6. Researchers Scale to assess the Severity of Epilepsy in Kids
7. Researchers trick Alzheimers Enzyme
8. Researchers find new HIV hiding place
9. New Hair in 15 Days Could Now Be A Possibility Say Researchers
10. Researchers developed world’s smallest toothbrus
11. Researchers discover receptor cells that can cause epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)...  AllianceRx Walgreens Prime, the combined central specialty pharmacy ... benefit manager Prime Therapeutics LLC (Prime), today officially began ... unveiling of new signage at its headquarters in ... a few other company-owned facilities across the country. This ... of whom will begin to see the AllianceRx Walgreens ...
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/22/2017)... 22, 2017  As the latest Obamacare repeal effort ... Cassidy (R-LA) and Lindsey Graham (R-SC) ... medical device industry is in an odd place.  The ... 2.3% excise tax on medical device sales passed along ... covered patients, increased visits and hospital customers with the ...
Breaking Medicine Technology: